Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decidual Stromal Cells in COVID-19 Induced Respiratory Failure
NCT04451291Phase 2Completed
- Sponsor
- University Health Network
- Start
- Sep 2020
- Primary completion
- Nov 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of decidua stroma cells in acute respiratory distress syndrome (ARDS), sponsored by University Health Network. Started Sep 2020; status: completed.
02
Drugs
decidua stroma cells
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04451291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04451291.